The Board of Directors of Sapporo Clinical Laboratory Inc. has authorized a buyback plan on May 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,070 JPY | -0.93% | -1.29% | +6.89% |
1st Jan change | Capi. | |
---|---|---|
+6.89% | 22.96M | |
-12.48% | 8.63B | |
+33.44% | 1.33B | |
+7.30% | 421M | |
+10.01% | 283M | |
+10.56% | 225M | |
-8.26% | 85.65M | |
+23.80% | 59.84M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.